KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1370 |
|---|---|
| Product Name | Anti-Human ERBB3 & CD221 Recombinant Antibody |
| Molecular Name | Istiratumab |
| Alias | Anti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab |
| CAS Number | 1509928-04-4 |
| Target | ERBB3 & CD221[Homo sapiens] |
| Isotype | IgG1 Kappa -[scFv]2 |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Background | Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
